Clinical Trials Directory

Trials / Completed

CompletedNCT00670787

Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial

A Randomized Trial to Establish the Effects of Combination Pill of Losartan Potassium and Hydrochlorothiazide on Medication Compliance Among Patients With High Blood Pressure.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
207 (actual)
Sponsor
Kyushu University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine whether combination pill of losartan potassium and hydrochlorothiazide will improve medication compliance among patients with high blood pressure.

Detailed description

Despite clear evidence that blood pressure lowering treatment is beneficial for reduction of cardiovascular disease, blood pressure levels are not adequately controlled in many hypertensive patients. More intensive blood pressure lowering treatment is required to achieve maximum reduction of cardiovascular disease. Combination pills of blood pressure lowering drugs could be a safe and effective strategy to achieve blood pressure target but there is no randomized evidence that established the beneficial effects of combination pills of blood pressure lowering drugs. The purpose of the study is to determine whether combination pill of losartan potassium and hydrochlorothiazide will improve medication compliance among patients with high blood pressure.

Conditions

Interventions

TypeNameDescription
DRUGCombination pill of losartan and hydrochlorothiazideCombination pill of losartan potassium 50mg and hydrochlorothiazide 12.5mg in the morning

Timeline

Start date
2008-06-01
Primary completion
2010-11-01
Completion
2011-02-01
First posted
2008-05-02
Last updated
2011-03-07

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00670787. Inclusion in this directory is not an endorsement.